|
|
||||||||
Cardiovascular Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota 55455
| |
ABSTRACT |
|---|
|
|
|---|
Left ventricular (LV) hypertrophy (LVH) results in a fetal shift in myocardial creatine kinase (CK) expression. Because CK plays an important role in intracellular energy production, transport, and utilization, this study was performed to characterize changes in CK expression and CK flux in severe pressure-overload LVH. Ascending aortic banding in 8-wk-old dogs resulted in LVH with a 92% increase in relative LV mass. In LVH hearts, CK-M isoform mRNA was decreased by 40% (P = 0.05) and protein was decreased by 50% (P < 0.01), whereas mitochondrial CK protein was decreased by 22% (P < 0.05). CK-B isoform mRNA was undetectable in normal hearts but was prominently expressed in LVH (P < 0.01); CK-B protein was increased by more than 10-fold in LVH (P < 0.01). Despite these changes, total CK activity was normal in LVH. Myocardial CK flux was examined using 31P magnetic resonance spectroscopy magnetization transfer. The CK forward rate constant was similar in normal and LVH hearts at baseline and did not change in either group during dobutamine treatment. In hearts with LVH, the CK forward flux rate was reduced by ~60% (P < 0.05) and decreased further during dobutamine. Thus, although pressure-overload LVH caused alterations of expression of both CK mRNA and protein levels, LV performance and oxygen consumption in response to dobutamine were normal. However, myocardial free ADP was increased in LVH hearts. This finding suggests that the CK alterations result in a need for higher ADP levels to maintain ATP synthesis in the hypertrophied heart.
high-energy phosphates; nuclear magnetic resonance; phosphocreatine; ATP
| |
INTRODUCTION |
|---|
|
|
|---|
IN THE HEART, ATP is synthesized mainly in the mitochondria through oxidative phosphorylation and transported to the contractile apparatus, where it is consumed by myosin ATPase to generate force. The creatine kinase (CK) system plays an important role in myocardial energy metabolism by maintaining ADP levels high at the mitochondria, where ATP is generated, and low at sites of ATP utilization (21, 45). The latter is postulated to contribute to the maintenance of a high free energy of ATP hydrolysis, thereby enhancing the efficiency of the energy utilization processes (43). In addition, a CK shuttle has been proposed, wherein high-energy phosphate transport within the cell is facilitated by the higher diffusibility of creatine and phosphocreatine (PCr) relative to ADP (5, 44).
In postinfarction-remodeled hearts and in failing hearts, a fetal shift of myocardial CK expression has been reported, with a decrease in the MM-isoform and increases in the MB- and BB-isoforms (9, 14, 16-19). Similar findings were observed in a canine model of left ventricular (LV) hypertrophy (LVH) produced by ascending aortic banding (42). Although the mechanism and functional consequences of these CK isoform shifts in the overloaded and failing heart are unclear, previous studies have demonstrated that decreases of CK activity have the potential to affect myocardial performance. Thus in rats in which the CK system was inhibited with iodoacetate or by chronic feeding of a creatine analog, the ability of the heart to respond to an increased workload was impaired (22, 40). In transgenic mice lacking CK-MM and mitochondrial CK (CK-mito), a higher myocardial free ADP concentration was required to maintain ATP synthesis (33, 34). Consequently, the present study was performed to determine whether abnormal CK isoform expression during pressure-overload hypertrophy induces alterations in high-energy phosphate kinetics that limit contractile performance. mRNA and protein levels of the CK isoforms were examined in hypertrophied and normal hearts, and 31P magnetic resonance spectroscopy (MRS) was used to determine whether the change in isoform expression in the hypertrophied heart was associated with a change of the CK flux rate.
| |
METHODS |
|---|
|
|
|---|
Studies were performed in accordance with the "Position of the American Heart Association on Research Animal Use," and protocols were approved by the Animal Care Committee of the University of Minnesota.
Production of LVH. Fourteen mongrel dogs (8 wk of age) were anesthetized with pentobarbital sodium (25-30 mg/kg iv), intubated, and ventilated with a respirator. A right thoracotomy was performed in the third intercostal space, and the ascending aorta, ~1.5 cm above the aortic valve, was mobilized and encircled with a polyethylene band 2.5 mm in width (2). When the LV and distal aortic pressures were measured, the band was tightened until a peak systolic pressure gradient of 20-30 mmHg was achieved across the narrowing. The chest was then closed, the pneumothorax was evacuated, and the animals were allowed to recover. LVH occurred progressively as the area of aortic constriction remained fixed in the face of normal body growth. At ~1 yr of age, animals were returned to the laboratory for study.
Experimental preparation.
Fourteen animals with LVH, as well as ten normal animals that served as
a control group, were premedicated with morphine sulfate (1 mg/kg sc)
and anesthetized with
-chloralose (100 mg/kg iv followed by an
infusion of 10 mg · kg
1 · h
1). Animals
were intubated and ventilated with a respirator with supplemental
oxygen; arterial blood gases and pH were maintained within the
physiological range. A polyvinyl chloride catheter (outer diameter, 3.0 mm) filled with heparin-saline was introduced into the right femoral
artery and advanced into the ascending aorta. A left thoracotomy was
performed in the fifth intercostal space, and the heart was suspended
in a pericardial cradle. A heparin-saline-filled catheter was
introduced into the LV through the apical dimple and secured with a
purse-string suture. A similar catheter was placed into the left atrium
through the atrial appendage. An NMR surface coil was sutured to the
anterior LV wall overlying the region perfused by the left anterior
descending coronary artery. The surface coil was constructed of a
single turn of copper wire and incorporated a 33-pF capacitor; surface
coils were 28 mm in diameter, respectively. The surface coil leads were
connected to a balanced-tuned circuit external and perpendicular to the thoracotomy incision. The pericardial cradle was released, and the
heart was allowed to assume its normal position. Animals were placed on
a circulating water heating blanket, which maintained body core
temperature at 37 ± 1°C, and positioned within the magnet.
Myocardial blood flow.
Myocardial blood flow was measured with microspheres (diameter, 15 µM) labeled with 141Ce, 51Cr,
95Nb, 85Sr, or 46Sc (NEN; Boston,
MA). For each measurement, ~3 × 106 microspheres
were administered into the left atrial catheter. A reference sample of
arterial blood was withdrawn from the aortic catheter at a rate of 15 ml/min beginning 5 s before the microsphere injection and
continuing for 120 s. Radioactivity in the myocardial and blood
reference specimens was determined using a
-spectrometer (Packard;
Downers Grove, IL) at window settings chosen for the combination of
radioisotopes used during the study. Activity in each energy window was
corrected for overlapping activity and for background activity. As the
rate of withdrawal of the reference blood specimen (Qr) and
the radioactivity of the reference specimen (Cr) was known,
myocardial radioactivity (Cm) could be used to compute
blood flow (Qm) as follows: Qm = Qr × (Cm/Cr).
NMR technique.
Measurements were performed in a 40-cm bore 4.7-T magnet interfaced
with a Spectroscopy Imaging Systems (Fremont, CA) computer console as
previously described (13, 31). The LV pressure signal was
used to gate NMR data acquisition to the cardiac cycle, whereas
respiratory gating was achieved by triggering the ventilator to the
cardiac cycle between data acquisitions. Spectra were recorded in late
diastole with a pulse repetition time of 6-7 s. This repetition time allowed full relaxation for ATP and Pi resonances and
~95% relaxation for the PCr resonances (31). PCr
resonance intensities were corrected for this saturation.
Radiofrequency (RF) transmission and signal detection were performed
with previously described surface coils (13, 31, 46). A
capillary containing 15 µl of 3 M phosphonoacetic acid was placed at
the coil center to serve as a reference. The proton signal from water
was used to homogenize the magnetic field and to adjust the position of
the animal in the magnet so that the coil was at or near the magnet and
gradient isocenters (31). With the use of the static
magnetic field magnitude gradient and adiabatic inversion pulses,
signal origin was restricted to a column coaxial with the surface coil
(perpendicular to the LV wall); column dimensions were 23 × 23 mm
in LVH hearts and 18 × 18 mm in normal hearts (46,
47). Within this column, the signal was further localized to
five voxels across the LV wall from epicardium to endocardium using the
RF magnetic field magnitude generated by the surface coil gradient
(31). The details of the adiabatic inversion pulses, the
plane rotation adiabatic BIR-4 pulse, the Fourier coefficients, and the
multiplication factors employed to construct the voxels have been
previously reported (13, 31). Each set of spectra
consisted of 96 scans accumulated in a 10-min block of time. Chemical
shifts were measured relative to PCr, which was assigned a chemical
shift of
2.55 parts per million relative to 85% phosphoric acid.
Intracellular pH was determined from the chemical shift of
Pi relative to the PCr resonance peak (4).
Because of off-resonance problems associated with the ATP
resonance
peak, the ATP
resonance was integrated for determination of ATP
content. No baseline correction was used. Calibration of the epicardial
voxel ATP content was performed using chemically determined ATP in an
epicardial biopsy obtained at the conclusion of study.
Calculation of myocardial free ADP and
Pi.
Myocardial free ADP levels were calculated from the CK equilibrium
expression using an equilibrium constant (Keq)
of 1.66 × 109 and cytosolic pH = 7.1 as follows:
[ADP] = ([ATP] [Crfree])/([PCr] [H+]
Keq). PCr and ATP values were obtained from the
spectra calibrated with the biopsy-measured ATP levels. Free creatine
(Crfree) was calculated by subtracting the PCr values from
the biopsy measurement of total creatine. As reported by Katz et al.
(23), the myocardial Pi resonance partially
overlaps one of the resonances of 2,3-diphosphoglycerate (2,3-DPG)
in erythrocytes in LV cavitary blood. As a result, the baseline
Pi resonance in the present study was too small to be reliably separated from the 2,3-DPG resonance and from background noise. Consequently, Pi values were calculated as the
difference between the integral of the Pi region during
baseline conditions and during each experimental condition and are
reported as
Pi.
CK kinetics measured with 31P MRS saturation
transfer.
A double-tuned (200 MHz for 1H and 81 MHz for
31P) surface coil (diameter, 28 mm) was used for RF
transmission and signal detection as previously described
(27). A chemical shift selective (CHESS) pulse sequence
was employed to saturate the ATP
resonance (12); this
sequence consisted of a 90° Sinc RF excitation pulse followed by a
short half-sine gradient pulse in all three orthogonal axes to enhance
the dephasing of transverse magnetization. This CHESS sequence was
applied repetitively to ensure complete saturation of the ATP
resonance. The repetition time for signal acquisition of 12 s
provided fully relaxed ATP
and PCr resonances. Control spectra were
acquired with the saturation carrier frequency setting on the opposite
side of the PCr resonance with a frequency difference identical to that
between PCr and ATP
. The relative change of the PCr resonance
intensity between the saturated and control spectra is proportional to
the forward rate constant (kf) in the exchange
reaction between PCr and ATP (6, 27). All spectra were
recorded with a spectral width of 6,000 Hz.
ATP
) and
the intrinsic longitudinal relaxation time for PCr
(T1) were calculated based on the two-site
chemical exchange model (6, 27) as follows: kf = (
M/M0)/T

kf, where kf and
T1 represent the pseudo first-order rate
constant and the intrinsic longitudinal relaxation time of PCr,
respectively;
M = M0
Minfinite,
where M0 and Minfinite represent the
magnetization at saturation zero and infinite times, respectively; and
T
increased from 0 to infinity. The CK forward flux rate
(Fluxf) was calculated as the product of
kf and the myocardial PCr concentration
(Fluxf = kf [PCr]). Each set
of spectra for saturation transfer measurements required ~6.2 min.
Hemodynamic measurements. Aortic and LV pressures were measured with fluid-filled pressure transducers at midchest level. Data were recorded on an eight-channel direct writing recorder (Coulbourne Instruments; Lehigh Valley, PA). Hemodynamic data were recorded continuously throughout the study. Arterial blood gases were measured every 15 min, and the respirator was adjusted to maintain PO2, PCO2, and pH in the physiological range.
Experimental protocol.
Hemodynamic measurements and 31P MRS spectra were first
obtained under basal conditions. Midway through the 10-min MRS
acquisition period, a microsphere injection was performed for
determination of myocardial blood flow. After baseline data
acquisition was completed, the response to inotropic stimulation with
dobutamine (15 µg · kg
1 · min
1 iv) was
examined. After allowing 10 min to achieve steady-state conditions, we
repeated all measurements in the ensuing 30 min. The dobutamine
infusion rate was then increased to 30 µg · kg
1 · min
1 iv, and
all measurements were again obtained.
Tissue preparation.
At the conclusion of the study, an epicardial biopsy was taken from
four normal and four LVH ventricles using a biopsy forceps precooled to
70°C for subsequent analysis of ATP content using HPLC
(36). The animal was then euthanized, and the heart was excised. In six animals from each group, full-thickness myocardial specimens (~1 g each) were rapidly excised and frozen in liquid nitrogen for determination of CK isoform expression. Another
full-thickness myocardial specimen (~3 g in weight) was frozen for
determination of total creatine content (36). The heart
was then fixed in 10% buffered formalin, and the LV myocardium beneath
the surface coil was sectioned into three transmural layers from
epicardium to endocardium, weighed, and placed into vials for counting
of radioactivity.
Northern blot analysis for mRNA. RNA was extracted from frozen tissue samples (50-100 mg) using a commercial procedure (7). Cell components were disrupted and separated by centrifugation. RNA in the aqueous phase was precipitated with isopropanol and centrifuged, and the pellet was air-dried and reconstituted in RNase-free water. RNA (20 µg) was size fractionated by electrophoresis on 1% agarose formaldehyde gel in MOPS buffer for 3 h at 110 V; RNA standards (GIBCO-BRL; Grand Island, NY) were run with each gel. The RNA was then transferred to a Nytran (nylon) membrane using HETS transfer solution (Tel-Test; Friendswood, TX), prehybridized in denatured salmon sperm DNA in a Techne hybridizer (HB-1D; Cambridge, UK), and reacted with specific radioactive probes. A 100-bp human cDNA probe specific to CK-B (14), a 1,000-bp rat cDNA probe specific to CK-M (14), and a complementary DNA probe specific to the CK-mito subunit mRNA (14) were used. A Prime-It II random primer labeling kit (Stratagene) was used to radiolabel the probes with 31P-labeled nucleotides. The membrane was washed and placed in a plastic bag for autoradiography. The hybridization signal was quantitated using PhosphoImager SI (Molecular Dynamics). The membrane was stripped and sequentially reprobed after repeat prehybridization.
Protein extraction and Western blot analysis.
Frozen heart samples (~50 mg) were added to 1 ml of ice-cold buffer
[0.2 M potassium phosphate (pH 7.4) containing 5 mM EGTA, 5 mM
-mercaptoethanol, and 10% (vol/vol) glycerol] to release mitochondrial and cytoplasmic enzymes. Samples were homogenized at 4°C for 20 s, followed by incubation with gentle agitation and centrifugation, such that the supernatant contained the isoenzymes in an optimal yield (32). Protein concentration was
determined using a modified Lowry method (Sigma Diagnostics).
Myocardial supernatants were electrophoresed on a commercial agarose
gel system (Corning ACI, CIBA Corning Diagnostic; Medfield, MA).
Commercially prepared molecular-weight standards and purified proteins
(CK-MM, CK-MB, CK-BB, and CK-mito; all obtained from Aalto) were run as controls. The protein subunits were transferred for 1 h at 100 V
in transfer buffer (25 mM Tris, 192 mM glycine, and 20% methanol). Monoclonal mouse antibodies specific to CK-M and CK-B (OEM Concepts; Toms River, NJ) were sequentially directed against their respective protein subunits bound to the membrane. The membrane was incubated with
the appropriate secondary horseradish peroxidase-labeled (anti-mouse)
IgG antibody, washed in Tween-Tris-buffered saline solution before a
1-min incubation with enhanced chemiluminescent substrate (ECL,
Amersham), and exposed to X-ray film (XAR-5, Eastman Kodak) for 15 s-10 min. Densitometry was used for relative quantitation of the
CK protein subunits.
Total CK and CK activity.
Myocardial homogenates were prepared in ice-cold phosphate buffer [0.2
M potassium phosphate (pH 7.4) containing 5 mmol/l EGTA, 5 mmol/l
-mercaptol ethenyl, and 10% glycerol] to release cytoplasmic and
mitochondrial enzymes. Total CK activity in the supernatant was
measured at 37°C in a centrifugal spectrophotometric analyzer (Cobas
Bio, Roche Analytical Instruments; Nutley, NJ) using
N-acetylcysteine (NAC)-activated reagents (reagent for CK NAC, Roche Analytical Instruments) (32). Enzyme results
were expressed as international units of activity per milligram of total protein. Duplicate samples were electrophoresed and incubated with and without substrate (PCr) to exclude non-CK artifacts.
Data analysis. Hemodynamic data were measured from the chart recordings. Numerical values for PCr and ATP during each experimental condition were expressed as a percentage of the baseline value. 31P NMR spectra from the first, third, and fifth transmural voxels were taken to represent the subepicardium (Epi), midmyocardium, and subendocardium (Endo), respectively (31). Hemodynamic, biochemical, and blood flow data were analyzed with one-way analysis of variance with replications. A value of P < 0.05 was required for significance. When the ANOVA yielded a significant result, individual comparisons were made using the method of Scheffé's. Data are reported as means ± SE.
| |
RESULTS |
|---|
|
|
|---|
Anatomic data. In 10 normal control animals, body weights ranged from 17.5 to 22.0 kg (mean = 20.0 ± 0.5 kg), LV weights ranged from 82.8 to 113.6 g (mean = 94.7 ± 3.9 g), and LV-to-body weight ratios ranged from 3.99 to 5.98 g/kg (mean = 4.91 ± 0.26 g/kg). In animals with aortic banding, body weights ranged from 17.5 to 30.0 kg (mean = 21.7 ± 1.2 kg) and LV weights ranged from 154.3 to 299.3 g (mean = 201.8 ± 13.7 g) and were significantly greater than normal (P < 0.01). LV-to-body weight ratios in animals with aortic banding ranged from 6.75 to 15.8 g/kg (mean = 9.45 ± 0.63 g/kg) and averaged 92% greater than in the normal animals (P < 0.01). None of the animals with LVH had clinical evidence of heart failure.
Hemodynamic data.
Hemodynamic measurements are shown in Table
1. Under basal conditions, heart rates
and mean aortic pressures were similar in normal and LVH animals. LV
systolic and end-diastolic pressures were higher in LVH than in normal
hearts (P < 0.05), and the heart rate × LV
systolic pressure product [rate-pressure product (RPP)] was also
higher in the hypertrophy group (P < 0.05). In
response to the first dose of dobutamine, the RPP increased
significantly in both groups (Table 1; P < 0.05).
Normal hearts showed a greater increase of heart rate, whereas LVH
animals showed a greater increase of LV systolic pressure. During
dobutamine (30 µg · kg
1 · min
1)
treatment, both groups had further increases of heart rate, LV systolic
pressure, and RPP. However, the increase of LV systolic pressure
reached significance only in normal hearts (Table 1). Mean aortic
pressure and LV end-diastolic pressure did not change significantly
during catecholamine infusion in either group (Table 1).
|
Myocardial blood flow and oxygen consumption.
Under basal conditions, blood flow per gram of myocardium was similar
in the two groups (Table 2). The
Endo-to-Epi flow ratio tended to be lower the hearts with LVH, but this
difference was not significant. In response to the first dose of
dobutamine, both groups showed increases of myocardial blood flow, but
in the normal animals this was significant only in the subepicardial layer (Table 2). During dobutamine (30 µg · kg
1 · min
1), there
was a further increase in myocardial blood flow. In the animals with
LVH, this increase tended to be greater in the Epi layer, although the
difference was not significant. The myocardial oxygen consumption
(M
O2) measured in six normal hearts and
six hearts with LVH is shown in Table 3.
There was no significant difference in oxygen extraction or in oxygen
consumption per gram of myocardium between normal and LVH hearts.
|
|
31P NMR measurements.
Transmural sets of 31P NMR spectra from a normal heart and
from a heart with LVH under baseline conditions and during dobutamine infusion are shown in Fig. 1. Myocardial
PCr/ATP and Pi/PCr are summarized in Table
4. Spectra recorded during the control
period were characterized by high PCr and ATP levels in both the normal and LVH hearts, whereas Pi was too low to identify at the
signal-to-noise ratio of the spectra. However, in response to
dobutamine stimulation, both groups showed decreases of PCr/ATP and
increases of Pi/PCr across the LV wall. These changes were
most pronounced in the hearts with LVH (Fig. 1 and Table 4).
|
|
Biopsy data.
Compared with normal hearts (n = 4), ATP and
total creatine contents were decreased by 34 and 15% in LVH hearts
(n = 4, each P < 0.05; Table
5). The rate of ATP synthesis, calculated
from the M
O2 values using the ratio
P:O = 3 (assuming that mitochondrial uncoupling was not present),
are also included in Table 5.
|
CK isoform expression.
As shown in Table 6 and Figs.
2 and 3,
in LVH hearts, CK-M mRNA was decreased by 40% (P = 0.05) and CK-M protein was decreased by 50% (P < 0.01). CK-B mRNA was increased, with the ratio of mRNA to 18S rRNA of
0.22 ± 0.09 compared with 0.0 ± 0.0 in the normal hearts
(P < 0.01); CK-B protein was increased by more than 10-fold in the LVH hearts (P < 0.01). CK-mito
protein was decreased by 22% (P < 0.05) in LVH
hearts.
|
|
|
Total CK activity.
Total CK activity was 228 ± 94 and 306 ± 76 IU · mg
wet weight cardiac
protein
1 · min
1 · g dry
weight
1 for normal and LVH hearts, respectively
(P = not significant).
CK kinetics.
The CK kinetic data are summarized in Table
7. Under basal conditions, the
M/M0 ratio (which is linearly related to the CK flux
rate) was similar in normal and LVH hearts. There was no significant
change in
M/M0 in response to dobutamine in either normal or LVH hearts (Table 7 and Figs. 4
and 5). T1 and
kf were not different between normal and LVH
hearts.
|
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The hearts with LVH in the present study were characterized by significant decreases of myocardial PCr, creatine, and the PCr-to-ATP ratio as well as a 30% reduction of ATP. In animals with pacing-induced heart failure, Shen et al. (38) observed that myocardial creatine fell progressively as heart failure developed so that the PCr-to-ATP ratio remained essentially unchanged. In the present study, myocardial total creatine content was decreased in the hypertrophied hearts, but this decrease was insufficient to maintain a normal PCr-to-ATP ratio, implying that myocardial free ADP was increased (Table 6). When ADP is increased, adenylate kinase (myokinase) is activated to catalyze the transfer of a phosphoryl group between two molecules of ADP to generate ATP and AMP (11, 21). The increased AMP by itself or in conjunction with allosteric stimulation of 5'-nucleotidase augments conversion of AMP to adenosine (25). Unlike the adenine nucleotides, which do not cross the sarcolemma, adenosine can cross the cell membrane to enter the interstitial space, where it is further degraded to inosine and hypoxanthine and carried out of the heart by the coronary circulation (15). Loss from the adenine nucleotide pool is of considerable consequence, because regeneration of ATP must then occur through de novo synthesis, a slow and energy-costly process (25). Cumulative loss of ATP during episodes of exercise or other stress exceeding the ability for de novo synthesis could explain the depletion of myocardial ATP observed in the hypertrophied ventricles.
Myocardial CK isoform expression. Previous studies of experimental models of compensated cardiac hypertrophy have reported an increase of the fetal isoenzymes CK-MB and CK-BB, generally without change of CK-MM or CK-mito and no change in total CK activity (18, 42), whereas reductions of total CK activity and CK-mito were reported to occur in the setting of cardiac failure (9, 16, 17, 19). These results suggested that the accumulation of B- containing CK isoenzyme is a marker of hypertrophy, whereas decreases of CK-MM and CK-mito are markers of pump failure. In the present study, Western blot analysis demonstrated a 50% decrease of CK-M protein in the hypertrophied hearts as well as a marked increase in CK-B protein. The results of Northern blot analysis with probes specific for CK-M and CK-B demonstrated that the change in protein isoenzyme expression was mediated at the level of mRNA abundance. Although posttranscriptional influences on mRNA stability cannot be excluded, previous studies in myogenic cell lines have demonstrated that the CK-M and CK-B genes are regulated at the level of transcription (41). In addition to the decreased CK-M protein, the animals with hypertrophy in the present study demonstrated a 22% decrease of CK-mito protein, but total CK activity per milligram protein was not significantly different between the hypertrophied and normal hearts. Although detailed evaluation of myocardial contractile performance could not be performed in the magnet during these studies, the animals demonstrated no evidence of cardiac failure. LV end-diastolic pressure was modestly increased, but this likely was the result of a decrease in chamber compliance secondary to the increased wall thickness. Thus the present study indicates that severe pressure-overload hypertrophy can be associated with significant reductions of both CK-mito and CK-M protein expression in the absence of overt LV failure.
The more than 10-fold increase in CK-B protein in the present study was greater than that generally reported in other experimental models of compensated myocardial hypertrophy and may be related to the greater degree of hypertrophy in the present study. Schultz et al. (39) speculated that the increased CK-B isoform in the hypertrophied heart may act to compensate for the decreased CK-M expression. However, the increase in CK-B cannot be ascribed simply to a reciprocal compensatory change in response to the decreased CK-M expression, because Saupe et al. (33) demonstrated that deletion of the genes for CK-M and CK-mito did not result in an increase of CK-B protein. Ingwall et al. (20) suggested that an increase of CK-MB may be a favorable adaptation, because the affinity of CK-MB for PCr is greater than the affinity of CK-MM for PCr. However, Saupe et al. (33) recently demonstrated that the CK reaction velocity measured in vivo was not higher for CK-BB than for CK-MM, suggesting that the isoenzyme shift toward the fetal pattern confers no obvious kinetic advantage. It is possible that the increased CK-B expression is the result of either the increased hemodynamic load or the resultant myocyte hypertrophy that was present in animals with LV outflow obstruction.Myocardial free ADP levels.
Oxidative phosphorylation involves the synthesis of ATP from ADP and
Pi, coupled to reduction of oxygen using electrons
extracted from mitochondrial NADH. The relative importance of each
substrate [ADP, O2, Pi, and intramitochondrial
NADH (NADHm)] is determined by its level compared with its
limiting Michaelis-Menten constant (Km) and
inhibition constant. Thus studies in perfused hearts have demonstrated
that it is possible to achieve the same ATP synthesis rate at
distinctly different intracellular levels of ADP, ATP, and
Pi (10). For example,
M
O2 (ATP synthesis rate) can be
maintained despite a decrease of NADHm, but only if ADP and/or Pi are appropriately increased (10).
Possible explanations for the higher ADP levels in the hypertrophied
hearts in the present study include decreased oxygen availability to
the mitochondria; an increased Km value for
oxygen with regard to cytochrome aa3; reduced
Pi availability to the mitochondrial ATPase; reduced NADH generation resulting from either inadequate exogenous carbon substrate or disordered intermediary metabolism; altered function of the electron
transport chain so that a lower mitochondrial proton gradient is
maintained; or altered properties of the mitochondrial ATPase or the
adenine nucleotide translocase so that the maximum velocity or
Km values with respect to ADP are increased
(28). We (3, 48) have previously
demonstrated that deoxymyoglobin is undetectable in normal or
hypertrophied hearts during either basal conditions or catecholamine
stimulated increases of work state, so that oxygen insufficiency cannot
account for the increased ADP level. Although limitation of carbon
substrate delivery to the myocyte is unlikely, alterations of substrate
preference have been described in the hypertrophied heart, including
decreased free fatty acid uptake and increased glucose uptake and
glycolysis (1, 8, 46), with an increased ratio of inactive
to active pyruvate dehydrogenase (37). These abnormalities
could result in lower steady-state NADHm levels and might
also limit the rate of NADHm generation (10).
A possible consequence of these alterations would be a compensatory
increase of cytosolic ADP to maintain ATP production at the level
required by the ATP utilization rate. This alteration might explain, at
least in part, the increased ADP levels in the hypertrophied hearts.
Myocardial CK flux rates. Because the CK activity measured in myocardial homogenates was not significantly different between normal and LVH hearts, one might expect that the higher ADP levels in the hypertrophied hearts would result in greater forward flux through the CK reaction. However, the mean CK activity determined in myocardial homogenates neglects the effects of the intracellular localization of the CK isoenzymes. Thus CK-MM located in association the myosin ATPase consumes ADP produced during contraction to regenerate ATP for use by the contractile apparatus (43). CK-mito localized in association with the adenine nucleotide translocator can utilize ATP to generate PCr, thereby maintaining high local ADP levels available for ATP synthesis but relatively lower mean cytosolic ADP levels (45). Because the CK-B isoform is not similarly localized within the myocyte, the increased CK-B in the hypertrophied heart may not reproduce the specific functions of CK-MM and CK-mito but does contribute to chemically determined total CK activity.
The alterations in the hypertrophied hearts mirror the findings reported by Perry et al. (29) in the developing rabbit heart, where the marked decrease in CK-B expression with increased CK-mito and CK-M that occurred between birth and 3 wk of age was associated with a striking increase in CK flux measured with the saturation transfer technique despite constant total CK activity. In the fetal heart, high ADP levels were associated with low CK flux rates even though total CK activity was not different from that in the adult heart (29). The investigators interpreted these findings to indicate that the intracellular compartmentation of CK in the adult myocyte results in increased CK flux rates (29). In a subsequent study, Portman and Ning (30) observed that increases of cardiac work produced by epinephrine infusion resulted in increases of free ADP in newborn sheep, whereas in mature sheep ADP tended to decrease with increasing workload. As in the hypertrophied hearts in the present study, the increase in workload in the newborn sheep was associated with a decrease in the CK flux rate despite increased calculated free ADP. They pointed out that in vivo M
O2 kinetics cannot be predicted from
Michaelis-Menten models derived from in vitro data (30)
and suggested that, in the newborn heart, the relationship between
substrates and CK flux might be explained using a rapid equilibrium
random-exchange model (26, 35). They considered whether,
in the newborn myocardium, CK inhibition might occur because of
formation of dead-end enzyme-MgADP-creatine complexes that could reduce
available enzyme binding sites and thus decrease the reaction rate
during high cardiac workloads. However, as in the present study, the
calculated free ADP values observed during high workloads were not in
the range where this form of inhibition might be expected to occur
(30). In any event, the increased ADP in association with
a lower CK flux rate in the hypertrophied hearts in the present study
mirrors similar responses to increases of workload that occur in the
fetal or newborn heart and are consistent with the concept that an
alteration in the pathway for mitochondrial regulation exists in the
hypertrophied hearts that is similar to that in the less ordered fetal
or neonatal heart.
In agreement with previous studies (27, 30), the CK
forward flux rate in the normal heart was more than an order of
magnitude greater than the calculated ATP synthesis rate. Similar to
previous studies in normal adult hearts of large animals, the CK
forward flux rate did not increase during the increase in oxygen
consumption produced by dobutamine infusion (24, 27, 30).
Although the CK kf was not different between the
normal and LVH groups, the forward flux rate was decreased by nearly
half in the hypertrophied hearts as a result of the decreased PCr
content. Even in the hypertrophied hearts, however, the CK flux rate
was seven- to eightfold greater than the ATP utilization rate, implying
that the observed decreased CK flux rate could not contribute to
impairment of contractile function. In previous studies, contractile
reserve was decreased in hearts in which the CK system was markedly
inhibited by sulfhydryl inhibition (40), by guanidino
substrate replacement (22), or by CK-M subunit gene
knockout (33, 34), suggesting that the CK system can
facilitate myocardial energy metabolism during high cardiac work
states. In support of this, Wallimann et al. (44)
demonstrated that optimal cross-bridge function of the contractile
apparatus could be achieved only if the CK system was present.
Nevertheless, the results of the present study indicate that in
compensated pressure-overload hypertrophy, neither the decreased basal
high-energy phosphate levels nor the decreased CK flux rate limited LV
function during catecholamine stimulation. This finding is supported by
our previous observation that dogs with severe pressure-overload LVH
could perform heavy treadmill exercise to the same level as normal
animals while achieving M
O2 values at
least as great as normal (2).
In conclusion, CK-M and CK-mito were significantly decreased, whereas
CK-B was markedly increased, in hearts with severe pressure-overload LVH, but total CK activity was not significantly different from normal.
Although the CK forward flux rate and Endo PCr-to-ATP ratios were lower
than normal, the hypertrophied hearts were able to develop marked
increases in LV systolic pressure and in the rate of ATP synthesis
(M
O2) in response to dobutamine
stimulation, indicating that the observed alterations in myocardial CK
expression did not limit contractile reserve.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Arnold W. Strauss, who kindly provided the probe and antibody for CK-M.
| |
FOOTNOTES |
|---|
* Authors contributed equally to this paper.
This work was supported by National Heart, Lung, and Blood Institute Grants HL-21872, HL-33600, HL-50470, HL-58067, and HL-61353. J. Zhang was the recipient of an Established Investigator Award from the American Heart Association.
Address for reprint requests and other correspondence: J. Zhang, Cardiovascular Div., Dept. of Medicine, Univ. of Minnesota Medical School, Mayo Mail Code 508, UMHC, 420 Delaware St. SE, Minneapolis, MN 55455 (E-mail: zhang047{at}tc.umn.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 31 August 2000; accepted in final form 22 March 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Allard, MF,
Schönekess BO,
Henning SL,
English DR,
and
Lopaschuk GD.
Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied heart.
Am J Physiol Heart Circ Physiol
267:
H742-H750,
1994
2.
Bache, RJ,
and
Dai XZ.
Myocardial oxygen consumption during exercise in the presence of left ventricular hypertrophy secondary to supravalvular aortic stenosis.
J Am Coll Cardiol
15:
1157-1164,
1990[Abstract].
3.
Bache, RJ,
Zhang J,
Murakami Y,
Zhang Y,
Cho YK,
Merkle H,
Gong G,
From AHL,
and
Ugurbil K.
Myocardial oxygenation at high workstates in hearts with left ventricular hypertrophy.
Cardiovasc Res
42:
616-626,
1999
4.
Bailey, IQ,
Seymour AM,
and
Radda G.
A 31P-NMR study of the effects of reflow on the ischaemic rat heart.
Biochim Biophys Acta
637:
1-7,
1981[Medline].
5.
Bessman, SP,
and
Carpenter CL.
The creatine-creatine phosphate energy shuttle.
Annu Rev Biochem
54:
831-862,
1985[ISI][Medline].
6.
Bittle, JA,
and
Ingwall JS.
Reaction rates of creatine kinase and ATP synthesis in the isolated rat heart. A 31P NMR magnetization transfer study.
J Biol Chem
260:
3512-3517,
1985
7.
Chomczynski, P.
A reagent for the single-step simultaneous isolation of RNA, DNA, and proteins from cell and tissue samples.
Biotechniques
15:
532-536,
1993[ISI][Medline].
8.
Christe, ME,
and
Rodgers RL.
Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat.
J Mol Cell Cardiol
26:
1371-1375,
1994[ISI][Medline].
9.
De Sousa, E,
Veksler V,
Minajeva A,
Kaasik A,
Mateo P,
Mayoux E,
Hoerter J,
Bigard X,
Serrurier B,
and
Ventura-Clapier RV.
Subcellular creatine kinase alterations: implications in heart failure.
Circ Res
85:
68-76,
1999
10.
From, AHL,
Zimmer SD,
Michurski SP,
Mohanakrishnan P,
Ulstad VK,
Thoma WJ,
and
Ugurbil K.
Regulation of the oxidative phosphorylation rate in the intact cell.
Biochemistry
29:
3731-3743,
1990[Medline].
11.
Gorman, MW,
Ning XH,
He MX,
Portman MA,
and
Sparks HV.
Adenosine release and high energy phosphates in intact dog hearts during norepinephrine infusion (Abstract).
Circ Res
70:
1146,
1992
12.
Haase, A,
Frahmn J,
Hanicke W,
and
Matthaei D.
1H NMR chemical shift selective (CHESS) imaging.
Phys Med Biol
30:
341-344,
1985[ISI][Medline].
13.
Hendrich, K,
Merkle H,
Weisdorf S,
Vine W,
Garwood M,
and
Ugurbil K.
Phase modulated rotating frame spectroscopic localization using an adiabatic plane rotation pulse and a single surface coil.
J Magn Reson
92:
258-275,
1991[ISI].
14.
Hoang, CD,
Zhang J,
Payne RM,
and
Apple FS.
Post-infarction left ventricular remodeling induces changes in creatine kinase mRNA and protein subunit levels in porcine myocardium.
Am J Pathol
151:
257-264,
1997[Abstract].
15.
Imai, S,
Riley AL,
and
Berne RM.
Effect of ischemia on adenine nucleotides in cardiac and skeletal muscle.
Circ Res
15:
443-450,
1964
16.
Ingwall, JS.
The hypertrophied myocardium accumulates the MB-creatine kinase isozyme.
Eur Heart J
5:
129-139,
1984.
17.
Ingwall, JS.
Is cardiac failure a consequence of decreased energy reserve?
Circulation
87, SupplVII:
58-62,
1993[ISI].
18.
Ingwall, JS.
Is the failing myocardium energy-starved? The role of the creatine kinase system.
Heart Failure
10:
128-135,
1994.
19.
Ingwall, JS,
Atkinson DE,
Clarke K,
and
Fetters JK.
Energetic correlates of cardiac failure: changes in the creatine kinase system in the failing myocardium.
Eur Heart J
11:
108-115,
1990
20.
Ingwall, JS,
Kramer MF,
Fifer MA,
Lorell BH,
Shemin R,
Grossman W,
and
Allen PD.
The creatine kinase system in normal and diseased human myocardium.
N Engl J Med
313:
1050-1054,
1985[Abstract].
21.
Iyengar, MR.
Creatine kinase as an intracellular regulator.
J Muscle Res Cell Motil
5:
527-534,
1984[ISI][Medline].
22.
Kapelko, VI,
Kupriyanov VV,
Novikova NA,
Lakomkin VL,
Steinschneider AY,
Severina MY,
Veksler VI,
and
Saks VA.
The cardiac contractile failure induced by chronic creatine and phosphocreatine deficiency.
J Mol Cell Cardiol
20:
465-479,
1988[ISI][Medline].
23.
Katz, LA,
Swain JA,
Portman MA,
and
Balaban RS.
Intracellular pH and inorganic phosphate content of heart in vivo: a 31P-NMR study.
Am J Physiol Heart Circ Physiol
255:
H189-H196,
1988
24.
Katz, LA,
Swain JA,
Portman MA,
and
Balaban RS.
Relation between phosphate metabolites and oxygen consumption of heart in vivo.
Am J Physiol Heart Circ Physiol
256:
H265-H274,
1989
25.
Manfredi, JP,
and
Holmes EW.
Purine salvage pathways in myocardium.
Annu Rev Physiol
47:
691-705,
1985[ISI][Medline].
26.
Morrison, JF,
and
Cleland WW.
Isotopes exchange studies of the mechanism of the reaction catalyzed by adenosine triphosphate: creatine phosphotransferase.
J Biol Chem
241:
673-683,
1966
27.
Murakami, Y,
Zhang J,
Eijgelshoven MHJ,
Chen W,
Carlyle WC,
Zhang Y,
Gong G,
and
Bache RJ.
Myocardial creatine kinase kinetics in hearts with postinfarction left ventricular remodeling.
Am J Physiol Heart Circ Physiol
276:
H892-H900,
1999
28.
Ning, XH,
Zhang J,
Liu J,
Ye Y,
Chen SH,
From AHL,
Bache RJ,
and
Portman MA.
Signaling and expression for mitochondrial membrane proteins during left ventricular remodeling and contractile failure after myocardial infarction.
J Am Coll Cardiol
36:
282-287,
2000
29.
Perry, SB,
McAuliffe J,
Balschi JA,
Hickey PR,
and
Ingwall JS.
Velocity of the creatine kinase reaction in the neonatal rabbit heart: role of mitochondrial creatine kinase.
Biochemistry
27:
2165-2172,
1988[Medline].
30.
Portman, MA,
and
Ning XH.
Maturational changes in respiratory control through creatine kinase in heart in vivo.
Am J Physiol Cell Physiol
263:
C453-C460,
1992
31.
Robitaille, PM,
Merkle H,
Sublett E,
Hendrich K,
Lew B,
Path G,
From AHL,
Bache RJ,
and
Ugurbil K.
Spectroscopic imaging and spatial localization using adiabatic pulses and applications to detect transmural metabolite distribution in the canine heart.
Magn Reson Med
10:
14-37,
1989[ISI][Medline].
32.
Rosalki, SB.
An improved procedure for serum creatine phosphokinase determination.
J Lab Clin Med
69:
696-701,
1967[ISI][Medline].
33.
Saupe, KW,
Spindler M,
Hopkins JC,
Shen W,
and
Ingwall JS.
Kinetic, thermodynamic, and developmental consequences of deleting creatine kinase isoenzymes from the heart. Reaction kinetics of the creatine kinase isoenzymes in the intact heart.
J Biol Chem
275:
19742-19746,
2000
34.
Saupe, KW,
Spindler M,
Tian R,
and
Ingwall JS.
Impaired cardiac energetics in mice lacking muscle-specific isoenzymes of creatine kinase.
Circ Res
82:
898-907,
1998
35.
Schimerlik, MI,
and
Cleland WW.
Inhibition of creatine kinase by chromium nucleotides.
J Biol Chem
248:
8418-8423,
1973
36.
Sellevold, OFM,
Jynge P,
and
Aartad K.
High performance liquid chromatography: a rapid isocratic method for determining creatine compounds and adenosine nucleotides in myocardial tissue.
J Mol Cell Cardiol
18:
517-527,
1986[ISI][Medline].
37.
Seymour, AM,
and
Chatham JC.
The effects of hypertrophy and diabetes on cardiac pyruvate dehydrogenase activity.
J Mol Cell Cardiol
29:
2771-2778,
1997[ISI][Medline].
38.
Shen, W,
Asai K,
Uechi M,
Mathier MA,
Shannon RP,
Vatner SF,
and
Ingwall JS.
Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs.
Circulation
100:
2113-2128,
1999
39.
Shultz, D,
Su X,
Bishop SP,
Billadello J,
and
Dell'Italia LJ.
Selective induction of the creatine kinase-B gene in chronic volume overload hypertrophy is not affect by ACE-inhibitor therapy.
J Mol Cell Cardiol
29:
2665-2673,
1997[ISI][Medline].
40.
Tian, R,
and
Ingwall JS.
Energetic basis for reduced contractile reserve in isolated rat hearts.
Am J Physiol Heart Circ Physiol
270:
H1207-H1216,
1996
41.
Trask, RV,
and
Billadello JJ.
Tissue-specific distribution and developmental regulation of M and B creatine kinase mRNAs.
Biochim Biophys Acta
1049:
182-188,
1990[Medline].
42.
Vatner, DE,
and
Ingwall JS.
Effects of moderate pressure overload cardiac hypertrophy on the distribution of creatine kinase isozymes.
Proc Soc Exp Biol Med
175:
5-9,
1984[Abstract].
43.
Ventura-Clapier, R,
Saks VA,
Vassort G,
Lauer C,
and
Elizarova G.
Reversible MM-creatine kinase binding to cardiac myofibrils.
Am J Physiol Cell Physiol
253:
C444-C455,
1987
44.
Wallimann, T,
Wyss M,
Brdiczka D,
Nicolay K,
and
Eppenberger HM.
Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the "phosphocreatine circuit" for cellular energy homeostasis.
Biochem J
281:
21-40,
1992.
45.
Wyss, M,
Smeitink J,
Wevers RA,
and
Wallimann T.
Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism.
Biochim Biophys Acta
1102:
119-166,
1992[Medline].
46.
Zhang, J,
Duncker DJ,
Ya X,
Zhang Y,
Pavek T,
Wei H,
Merkle H,
Ugurbil K,
From AHL,
and
Bache RJ.
Effect of left ventricular hypertrophy secondary to chronic pressure overload on transmural myocardial glucose uptake: a 31P NMR spectroscopic study.
Circulation
92:
1274-1283,
1995
47.
Zhang, J,
Merkle H,
Hendrich K,
Garwood M,
From AHL,
Ugurbil K,
and
Bache RJ.
Bioenergetic abnormalities associated with severe left ventricular hypertrophy.
J Clin Invest
92:
993-1003,
1993.
48.
Zhang, J,
Murakami Y,
Zhang Y,
Cho YK,
Ye Y,
Gong G,
Bache RJ,
Ugurbil K,
and
From AHL
Oxygen delivery does not limit cardiac performance during high work states.
Am J Physiol Heart Circ Physiol
276:
H50-H57,
1999.
This article has been cited by other articles:
![]() |
J. Feygin, A. Mansoor, P. Eckman, C. Swingen, and J. Zhang Functional and bioenergetic modulations in the infarct border zone following autologous mesenchymal stem cell transplantation Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1772 - H1780. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tokarska-Schlattner, M. Zaugg, R. da Silva, E. Lucchinetti, M. C. Schaub, T. Wallimann, and U. Schlattner Acute toxicity of doxorubicin on isolated perfused heart: response of kinases regulating energy supply Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H37 - H47. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Joubert, J.-L. Mazet, P. Mateo, and J. A. Hoerter 31P NMR Detection of Subcellular Creatine Kinase Fluxes in the Perfused Rat Heart. CONTRACTILITY MODIFIES ENERGY TRANSFER PATHWAYS J. Biol. Chem., May 17, 2002; 277(21): 18469 - 18476. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||